
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Most Relevant Terms per Topic</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

td:nth-child(even){background-color: #f2f2f2;}

td:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Most Relevant Terms per Topic</h2>
<h3>Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 56</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th><a href="Topic_01.html" target="_blank">Topic 1</a></th>
      <th><a href="Topic_02.html" target="_blank">Topic 2</a></th>
      <th><a href="Topic_03.html" target="_blank">Topic 3</a></th>
      <th><a href="Topic_04.html" target="_blank">Topic 4</a></th>
      <th><a href="Topic_05.html" target="_blank">Topic 5</a></th>
      <th><a href="Topic_06.html" target="_blank">Topic 6</a></th>
      <th><a href="Topic_07.html" target="_blank">Topic 7</a></th>
      <th><a href="Topic_08.html" target="_blank">Topic 8</a></th>
      <th><a href="Topic_09.html" target="_blank">Topic 9</a></th>
      <th><a href="Topic_10.html" target="_blank">Topic 10</a></th>
      <th><a href="Topic_11.html" target="_blank">Topic 11</a></th>
      <th><a href="Topic_12.html" target="_blank">Topic 12</a></th>
      <th><a href="Topic_13.html" target="_blank">Topic 13</a></th>
      <th><a href="Topic_14.html" target="_blank">Topic 14</a></th>
      <th><a href="Topic_15.html" target="_blank">Topic 15</a></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1</th>
      <td>virus</td>
      <td>infection</td>
      <td>ZIKV</td>
      <td>detection</td>
      <td>CCHFV</td>
      <td>EBOV</td>
      <td>EVD</td>
      <td>LASV</td>
      <td>nss</td>
      <td>DENV</td>
      <td>aegypti</td>
      <td>viruses</td>
      <td>de</td>
      <td>SFTSV</td>
      <td>RGN</td>
    </tr>
    <tr>
      <th>2</th>
      <td>disease</td>
      <td>cell</td>
      <td>zika</td>
      <td>WNV</td>
      <td>vaccine</td>
      <td>ebola</td>
      <td>sierra</td>
      <td>lassa</td>
      <td>RVFV</td>
      <td>dengue</td>
      <td>aedes</td>
      <td>innate</td>
      <td>el</td>
      <td>SFTS</td>
      <td>natal</td>
    </tr>
    <tr>
      <th>3</th>
      <td>fever</td>
      <td>cells</td>
      <td>zika virus</td>
      <td>assay</td>
      <td>CCHF</td>
      <td>ebola virus</td>
      <td>leone</td>
      <td>arenavirus</td>
      <td>RVF</td>
      <td>serotypes</td>
      <td>mosquito</td>
      <td>NW</td>
      <td>dengue</td>
      <td>ab10</td>
      <td>hantaviruses</td>
    </tr>
    <tr>
      <th>4</th>
      <td>infections</td>
      <td>virus</td>
      <td>microcephaly</td>
      <td>nile</td>
      <td>challenge</td>
      <td>ebolavirus</td>
      <td>ebola virus disease</td>
      <td>arenaviruses</td>
      <td>valley</td>
      <td>dengue virus</td>
      <td>NIRVS</td>
      <td>RNA</td>
      <td>DHF/DSS</td>
      <td>oshima</td>
      <td>genotypes</td>
    </tr>
    <tr>
      <th>5</th>
      <td>clinical</td>
      <td>vitro</td>
      <td>pregnant</td>
      <td>encephalitis</td>
      <td>antibodies</td>
      <td>GP</td>
      <td>sierra leone</td>
      <td>lassa fever</td>
      <td>SFSV</td>
      <td>DIII</td>
      <td>mosquitoes</td>
      <td>contribute</td>
      <td>en</td>
      <td>gn</td>
      <td>DENV-2</td>
    </tr>
    <tr>
      <th>6</th>
      <td>africa</td>
      <td>activity</td>
      <td>fetal</td>
      <td>equine</td>
      <td>mice</td>
      <td>marburg</td>
      <td>international</td>
      <td>lassa virus</td>
      <td>rift</td>
      <td>CHIKV</td>
      <td>A.</td>
      <td>single-stranded</td>
      <td>las</td>
      <td>thrombocytopenia</td>
      <td>urban</td>
    </tr>
    <tr>
      <th>7</th>
      <td>outbreaks</td>
      <td>viral</td>
      <td>complications</td>
      <td>bats</td>
      <td>neutralizing</td>
      <td>marburg virus</td>
      <td>ebola</td>
      <td>MOPV</td>
      <td>phlebovirus</td>
      <td>serotype</td>
      <td>albopictus</td>
      <td>belong</td>
      <td>DV</td>
      <td>sftsv infection</td>
      <td>sylvatic</td>
    </tr>
    <tr>
      <th>8</th>
      <td>review</td>
      <td>JEV</td>
      <td>congenital</td>
      <td>sera</td>
      <td>neutralizing antibodies</td>
      <td>E-S-FLU</td>
      <td>outbreak</td>
      <td>LF</td>
      <td>bunyaviridae</td>
      <td>ERI3</td>
      <td>ae</td>
      <td>ocular</td>
      <td>dengue fever</td>
      <td>UPR</td>
      <td>disorder</td>
    </tr>
    <tr>
      <th>9</th>
      <td>health</td>
      <td>drug</td>
      <td>neurological</td>
      <td>west nile virus</td>
      <td>protection</td>
      <td>filovirus</td>
      <td>2014</td>
      <td>tfr1</td>
      <td>MP-12</td>
      <td>mabs</td>
      <td>scapularis</td>
      <td>filovirus</td>
      <td>con</td>
      <td>08-as</td>
      <td>côte</td>
    </tr>
    <tr>
      <th>10</th>
      <td>infection</td>
      <td>entry</td>
      <td>anti-zikv</td>
      <td>positive</td>
      <td>JUNV</td>
      <td>MARV</td>
      <td>liberia</td>
      <td>LCMV</td>
      <td>family bunyaviridae</td>
      <td>TF</td>
      <td>CHIKV</td>
      <td>filovirus disease</td>
      <td>fiebre</td>
      <td>thrombocytopenia syndrome</td>
      <td>d’ivoire</td>
    </tr>
    <tr>
      <th>11</th>
      <td>chikungunya</td>
      <td>antiviral</td>
      <td>adults</td>
      <td>ELISA</td>
      <td>expressing</td>
      <td>BCX4430</td>
      <td>island</td>
      <td>mammarenaviruses</td>
      <td>IFN</td>
      <td>million</td>
      <td>crosse</td>
      <td>OW</td>
      <td>paper</td>
      <td>sfts virus</td>
      <td>côte d’ivoire</td>
    </tr>
    <tr>
      <th>12</th>
      <td>cases</td>
      <td>identified</td>
      <td>zika virus infection</td>
      <td>DENV-4</td>
      <td>attenuated</td>
      <td>anti-ebola</td>
      <td>concern</td>
      <td>machupo</td>
      <td>degradation</td>
      <td>genus flavivirus</td>
      <td>DENV4</td>
      <td>primate</td>
      <td>coronavirus</td>
      <td>NSDV</td>
      <td>codon</td>
    </tr>
    <tr>
      <th>13</th>
      <td>humans</td>
      <td>study</td>
      <td>strains</td>
      <td>%</td>
      <td>protected</td>
      <td>e-s-flu virus</td>
      <td>patients</td>
      <td>ATP1A1</td>
      <td>PKR</td>
      <td>conformation</td>
      <td>I.</td>
      <td>immune</td>
      <td>infants</td>
      <td>host cell</td>
      <td>srips</td>
    </tr>
    <tr>
      <th>14</th>
      <td>viral</td>
      <td>therapeutic</td>
      <td>brazil</td>
      <td>test</td>
      <td>crimean-congo</td>
      <td>nonhuman</td>
      <td>rapid</td>
      <td>junin</td>
      <td>gc</td>
      <td>immunity</td>
      <td>vector</td>
      <td>chapter</td>
      <td>day</td>
      <td>5–10</td>
      <td>shell</td>
    </tr>
    <tr>
      <th>15</th>
      <td>models</td>
      <td>treatment</td>
      <td>pregnancy</td>
      <td>samples</td>
      <td>titers</td>
      <td>zaire</td>
      <td>populations</td>
      <td>ITCH</td>
      <td>rift valley fever virus</td>
      <td>mab</td>
      <td>adaptation</td>
      <td>VHF</td>
      <td>blood</td>
      <td>therapeutic agent</td>
      <td>c protein</td>
    </tr>
    <tr>
      <th>16</th>
      <td>recent</td>
      <td>in vitro</td>
      <td>AR-12</td>
      <td>flaviviruses</td>
      <td>prevent</td>
      <td>clomiphene</td>
      <td>presenting</td>
      <td>host factors</td>
      <td>sandfly</td>
      <td>DHF</td>
      <td>aedes aegypti</td>
      <td>negative-strand</td>
      <td>ratio</td>
      <td>TBEV</td>
      <td>r(2</td>
    </tr>
    <tr>
      <th>17</th>
      <td>animal</td>
      <td>mechanism</td>
      <td>women</td>
      <td>VEEV</td>
      <td>MAYV</td>
      <td>filoviridae</td>
      <td>case</td>
      <td>n-glycosylation</td>
      <td>genus phlebovirus</td>
      <td>DI/DII</td>
      <td>arboviruses</td>
      <td>innate immune response</td>
      <td>indic</td>
      <td>recovered</td>
      <td>YFV</td>
    </tr>
    <tr>
      <th>18</th>
      <td>countries</td>
      <td>inhibited</td>
      <td>emergency</td>
      <td>serological</td>
      <td>immune responses</td>
      <td>mabs</td>
      <td>contagious</td>
      <td>mammarenavirus</td>
      <td>virulence</td>
      <td>PRINT</td>
      <td>V920</td>
      <td>families</td>
      <td>5th</td>
      <td>272</td>
      <td>rainforest</td>
    </tr>
    <tr>
      <th>19</th>
      <td>associated with</td>
      <td>inhibitors</td>
      <td>defects</td>
      <td>specificity</td>
      <td>horse</td>
      <td>containment</td>
      <td>colombia</td>
      <td>endemic regions</td>
      <td>genus</td>
      <td>intraviral</td>
      <td>a. albopictus</td>
      <td>uorfs</td>
      <td>guidelines</td>
      <td>japan</td>
      <td>neurotropic</td>
    </tr>
    <tr>
      <th>20</th>
      <td>hemorrhagic</td>
      <td>replication</td>
      <td>neurological complications</td>
      <td>western</td>
      <td>envelope</td>
      <td>GP1</td>
      <td>planning</td>
      <td>life</td>
      <td>synthesis</td>
      <td>antibody-dependent enhancement</td>
      <td>aedes albopictus</td>
      <td>paramyxoviruses</td>
      <td>remote</td>
      <td>hokkaido</td>
      <td>CAI</td>
    </tr>
    <tr>
      <th>21</th>
      <td>mortality</td>
      <td>found</td>
      <td>fetal microcephaly</td>
      <td>virus</td>
      <td>mouse</td>
      <td>amps</td>
      <td>guinea</td>
      <td>world</td>
      <td>sandfly fever</td>
      <td>srece</td>
      <td>vectors</td>
      <td>hantavirus</td>
      <td>risk</td>
      <td>247</td>
      <td>rescued</td>
    </tr>
    <tr>
      <th>22</th>
      <td>current</td>
      <td>effect</td>
      <td>gossypol</td>
      <td>revealed</td>
      <td>induce</td>
      <td>ER</td>
      <td>transmission</td>
      <td>steps</td>
      <td>lacking</td>
      <td>donors</td>
      <td>la</td>
      <td>positive-sense</td>
      <td>epidemiological</td>
      <td>thrombocytopenia syndrome virus</td>
      <td>park</td>
    </tr>
    <tr>
      <th>23</th>
      <td>chikungunya virus</td>
      <td>compounds</td>
      <td>guillain-barré</td>
      <td>selected</td>
      <td>immunization</td>
      <td>ebolaviruses</td>
      <td>period</td>
      <td>interactions</td>
      <td>IRF3</td>
      <td>enhancement</td>
      <td>culex</td>
      <td>genome</td>
      <td>fever</td>
      <td>tick-borne</td>
      <td>june</td>
    </tr>
    <tr>
      <th>24</th>
      <td>febrile</td>
      <td>targets</td>
      <td>infected</td>
      <td>sensitivity</td>
      <td>vaccinated</td>
      <td>VSV</td>
      <td>potentially</td>
      <td>arenaviral</td>
      <td>protein</td>
      <td>dengue infection</td>
      <td>a. aegypti</td>
      <td>host</td>
      <td>dengue hemorrhagic fever</td>
      <td>china</td>
      <td>cuba</td>
    </tr>
    <tr>
      <th>25</th>
      <td>development</td>
      <td>drugs</td>
      <td>abnormalities</td>
      <td>immunosorbent</td>
      <td>humoral</td>
      <td>surface</td>
      <td>organization</td>
      <td>partially</td>
      <td>phleboviruses</td>
      <td>m366.6</td>
      <td>indian</td>
      <td>filoviruses</td>
      <td>primary</td>
      <td>host</td>
      <td>values</td>
    </tr>
    <tr>
      <th>26</th>
      <td>acute</td>
      <td>cellular</td>
      <td>syndrome</td>
      <td>benzavir-2</td>
      <td>TCRV</td>
      <td>antibody</td>
      <td>care</td>
      <td>choriomeningitis</td>
      <td>M847</td>
      <td>expressed</td>
      <td>mosquito vector</td>
      <td>flaviviruses</td>
      <td>nipah</td>
      <td>korea</td>
      <td>RT</td>
    </tr>
    <tr>
      <th>27</th>
      <td>severe</td>
      <td>domain</td>
      <td>barré</td>
      <td>primers</td>
      <td>lethal</td>
      <td>biosafety</td>
      <td>R(0</td>
      <td>process</td>
      <td>nss protein</td>
      <td>antibody-dependent</td>
      <td>arthropods</td>
      <td>family</td>
      <td>su</td>
      <td>proteomic</td>
      <td>CFR</td>
    </tr>
    <tr>
      <th>28</th>
      <td>endemic</td>
      <td>production</td>
      <td>testicular</td>
      <td>sensitive</td>
      <td>responses</td>
      <td>monoclonal</td>
      <td>persons</td>
      <td>OST</td>
      <td>MRC-5</td>
      <td>antigens</td>
      <td>2005</td>
      <td>prototype</td>
      <td>CD209</td>
      <td>spectrometry</td>
      <td>DR</td>
    </tr>
    <tr>
      <th>29</th>
      <td>illness</td>
      <td>highly</td>
      <td>vertical</td>
      <td>neutralization</td>
      <td>efficacy</td>
      <td>anti-ebov</td>
      <td>largest</td>
      <td>guanarito</td>
      <td>mrna</td>
      <td>examined</td>
      <td>la crosse virus</td>
      <td>profiling</td>
      <td>laboratory diagnosis</td>
      <td>predict</td>
      <td>inflict</td>
    </tr>
    <tr>
      <th>30</th>
      <td>including</td>
      <td>proteins</td>
      <td>sperm</td>
      <td>japanese</td>
      <td>recombinant</td>
      <td>bearing</td>
      <td>world health organization</td>
      <td>old world</td>
      <td>virulence factor</td>
      <td>dengue viruses</td>
      <td>31N</td>
      <td>systemic</td>
      <td>riesgo</td>
      <td>isolates</td>
      <td>PID</td>
    </tr>
    <tr>
      <th>31</th>
      <td>human</td>
      <td>binding</td>
      <td>asian</td>
      <td>NS1</td>
      <td>protective</td>
      <td>pseudotypes</td>
      <td>epidemic</td>
      <td>arenavirus infection</td>
      <td>DIVA</td>
      <td>estimated</td>
      <td>v920 vaccine</td>
      <td>leading</td>
      <td>epidemias</td>
      <td>infectious disease</td>
      <td>neighboring</td>
    </tr>
    <tr>
      <th>32</th>
      <td>west</td>
      <td>mechanisms</td>
      <td>fetuses</td>
      <td>capture</td>
      <td>MVA-CHIK</td>
      <td>sudan</td>
      <td>french polynesia</td>
      <td>arenaviridae</td>
      <td>ifn-β</td>
      <td>spectrum</td>
      <td>autochthonous</td>
      <td>ribosome profiling</td>
      <td>por</td>
      <td>reacted</td>
      <td>2006</td>
    </tr>
    <tr>
      <th>33</th>
      <td>emerging</td>
      <td>active</td>
      <td>infection</td>
      <td>flavivirus</td>
      <td>passive</td>
      <td>isomers</td>
      <td>health</td>
      <td>ML29</td>
      <td>rmp12-ptnss</td>
      <td>dengue vaccine</td>
      <td>i. scapularis</td>
      <td>ribosome</td>
      <td>definitive</td>
      <td>viral multiplication</td>
      <td>EGFP</td>
    </tr>
    <tr>
      <th>34</th>
      <td>morbidity</td>
      <td>inhibitory</td>
      <td>2015</td>
      <td>plaque</td>
      <td>disseminated</td>
      <td>survivors</td>
      <td>oceania</td>
      <td>involved</td>
      <td>rift valley fever</td>
      <td>tetravalent</td>
      <td>ocean</td>
      <td>define</td>
      <td>día</td>
      <td>cellular responses</td>
      <td>higher</td>
    </tr>
    <tr>
      <th>35</th>
      <td>south</td>
      <td>library</td>
      <td>ery-est</td>
      <td>BTV</td>
      <td>D746</td>
      <td>glycoprotein</td>
      <td>guatemala</td>
      <td>essential</td>
      <td>truncated</td>
      <td>joint</td>
      <td>U.S.</td>
      <td>reoviruses</td>
      <td>hasta</td>
      <td>hemorrhage</td>
      <td>=</td>
    </tr>
    <tr>
      <th>36</th>
      <td>limited</td>
      <td>target</td>
      <td>409</td>
      <td>CONCLUSION</td>
      <td>eastern europe</td>
      <td>filoviruses</td>
      <td>countries/territories</td>
      <td>multiplication</td>
      <td>rmp12-sfsnss</td>
      <td>ppis</td>
      <td>E2-L210Q</td>
      <td>polyprotein</td>
      <td>children</td>
      <td>alanine</td>
      <td>found</td>
    </tr>
    <tr>
      <th>37</th>
      <td>threat</td>
      <td>inhibitor</td>
      <td>fetus</td>
      <td>PRNT</td>
      <td>enhance</td>
      <td>full-length</td>
      <td>lung</td>
      <td>cycle</td>
      <td>tripartite</td>
      <td>germline-like</td>
      <td>larvae</td>
      <td>ocular manifestations</td>
      <td>south america</td>
      <td>HB28</td>
      <td>variation</td>
    </tr>
    <tr>
      <th>38</th>
      <td>molecular</td>
      <td>fusion</td>
      <td>male</td>
      <td>venezuelan equine encephalitis virus</td>
      <td>horses</td>
      <td>1976</td>
      <td>suriname</td>
      <td>host</td>
      <td>phosphorylation</td>
      <td>oligomerization</td>
      <td>spp</td>
      <td>adaptive immunity</td>
      <td>secondary</td>
      <td>ATF6</td>
      <td>strain</td>
    </tr>
    <tr>
      <th>39</th>
      <td>increased</td>
      <td>mice</td>
      <td>congenital zika syndrome</td>
      <td>west</td>
      <td>immunogenicity</td>
      <td>rvsv-based</td>
      <td>migration</td>
      <td>west africa</td>
      <td>mrc-5 cells</td>
      <td>challenging</td>
      <td>quinquefasciatus</td>
      <td>ssrna</td>
      <td>epidemics</td>
      <td>SD4</td>
      <td>discovered</td>
    </tr>
    <tr>
      <th>40</th>
      <td>potential</td>
      <td>potential</td>
      <td>guillain-barre</td>
      <td>antibodies</td>
      <td>E298</td>
      <td>ebolavirus species</td>
      <td>2013–2016</td>
      <td>anti-mammarenavirus</td>
      <td>self-limiting</td>
      <td>evolved</td>
      <td>ocean islands</td>
      <td>pathogenesis</td>
      <td>occidental</td>
      <td>scanning</td>
      <td>synthesizes</td>
    </tr>
    <tr>
      <th>41</th>
      <td>public health</td>
      <td>protein</td>
      <td>malformations</td>
      <td>results</td>
      <td>vaccines</td>
      <td>filoviral</td>
      <td>declared</td>
      <td>MAGT1</td>
      <td>chadox1</td>
      <td>contacts</td>
      <td>aedes spp</td>
      <td>members</td>
      <td>dv infection</td>
      <td>non-linear</td>
      <td>6.25</td>
    </tr>
    <tr>
      <th>42</th>
      <td>research</td>
      <td>effective</td>
      <td>birth</td>
      <td>TABV</td>
      <td>immune</td>
      <td>facilities</td>
      <td>wave</td>
      <td>vrnp</td>
      <td>domestic</td>
      <td>nanoparticles</td>
      <td>florida</td>
      <td>responses</td>
      <td>se</td>
      <td>biological processes</td>
      <td>shrews</td>
    </tr>
    <tr>
      <th>43</th>
      <td>worldwide</td>
      <td>prophylactic</td>
      <td>zika ns2b-ns3pro</td>
      <td>SUPPLEMENTARY</td>
      <td>study</td>
      <td>VP40</td>
      <td>2016</td>
      <td>TUSC3</td>
      <td>host</td>
      <td>palmitoylation</td>
      <td>county</td>
      <td>discuss</td>
      <td>resumen</td>
      <td>cross-linker</td>
      <td>uncovered</td>
    </tr>
    <tr>
      <th>44</th>
      <td>licensed</td>
      <td>aahig</td>
      <td>mothers</td>
      <td>authorized</td>
      <td>high</td>
      <td>entry</td>
      <td>time</td>
      <td>sabia</td>
      <td>factor</td>
      <td>NS2B</td>
      <td>female</td>
      <td>BRB</td>
      <td>exposures</td>
      <td>gangwon/korea/2012</td>
      <td>circulate</td>
    </tr>
    <tr>
      <th>45</th>
      <td>animal models</td>
      <td>nervous</td>
      <td>birth defects</td>
      <td>online</td>
      <td>ankara</td>
      <td>virus</td>
      <td>worker</td>
      <td>STT3B-OST</td>
      <td>fever</td>
      <td>billion</td>
      <td>land</td>
      <td>flow</td>
      <td>journey</td>
      <td>phage-displayed</td>
      <td>noteworthy</td>
    </tr>
    <tr>
      <th>46</th>
      <td>vaccine</td>
      <td>enhanced</td>
      <td>Z2</td>
      <td>version</td>
      <td>tick-borne disease</td>
      <td>species</td>
      <td>rico</td>
      <td>STT3B</td>
      <td>cells</td>
      <td>allosteric</td>
      <td>publications</td>
      <td>dendritic cells</td>
      <td>epidemiological control</td>
      <td>cell membrane fusion</td>
      <td>molecularly</td>
    </tr>
    <tr>
      <th>47</th>
      <td>trials</td>
      <td>countermeasures</td>
      <td>pregnant women</td>
      <td>DKNV</td>
      <td>testes</td>
      <td>pseudovirus</td>
      <td>martin</td>
      <td>prototypic</td>
      <td>family</td>
      <td>antigenically</td>
      <td>transmission</td>
      <td>APC</td>
      <td>menace</td>
      <td>1995</td>
      <td>fine-tuning</td>
    </tr>
    <tr>
      <th>48</th>
      <td>progress</td>
      <td>lines</td>
      <td>guillain-barré syndrome</td>
      <td>material</td>
      <td>vaccinia</td>
      <td>reston</td>
      <td>KGH</td>
      <td>virus infectivity</td>
      <td>punta toro virus</td>
      <td>golgi</td>
      <td>two-year</td>
      <td>threats</td>
      <td>collapse</td>
      <td>stem</td>
      <td>sophisticated</td>
    </tr>
    <tr>
      <th>49</th>
      <td>past</td>
      <td>CHK2</td>
      <td>semen</td>
      <td>bat</td>
      <td>hamsters</td>
      <td>biosafety level</td>
      <td>recrudescence</td>
      <td>mastomys natalensis</td>
      <td>eif2α</td>
      <td>confers</td>
      <td>manatee</td>
      <td>cytokines</td>
      <td>identifiable</td>
      <td>alteration</td>
      <td>dutch</td>
    </tr>
    <tr>
      <th>50</th>
      <td>clinical trials</td>
      <td>combination</td>
      <td>epidemic</td>
      <td>species</td>
      <td>competent</td>
      <td>anti-filovirus</td>
      <td>puerto</td>
      <td>transferrin</td>
      <td>toro</td>
      <td>ns</td>
      <td>triseriatus</td>
      <td>uorf</td>
      <td>count/basic</td>
      <td>goat</td>
      <td>predictor</td>
    </tr>
  </tbody>
</table>
</body>
</html>
